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Abstract 
 
Objective:  To identify differences between manufacturing firms in Nigeria that have 
undertaken HIV/AIDS prevention activities and those that have not as a step toward 
improving the targeting of HIV policies and interventions. 
 
Methods:  A survey of a representative sample of registered manufacturing firms in 
Nigeria, stratified by location, workforce size, and industrial sector.  The survey was 
administered to managers of 232 firms representing most major industrial areas and 
sectors in March-April 2001. 
 
Results:  45.3 percent of the firms’ managers received information about HIV/AIDS 
from a source outside the firm in 2000; 7.7 percent knew of an employee who was HIV-
positive at the time of the survey; and 13.6 percent knew of an employee who had left the 
firm and/or died in service due to AIDS.  Only 31.7 percent of firms took any action to 
prevent HIV among employees in 2000, and 23.9 percent had discussed the epidemic as a 
potential business concern.  The best correlates of having taken action on HIV were 
knowledge of an HIV-positive employee or having lost an employee to AIDS (odds ratio 
[OR] 6.36, 95% confidence interval [CI]:  2.30, 17.57) and receiving information about 
the disease from an outside source (OR 7.83, 95% CI:  3.46, 17.69). 
 
Conclusions:  Despite a nationwide HIV seroprevalence of 5.8 percent, as of 2001 most 
Nigerian manufacturing firm managers did not regard HIV/AIDS as a serious problem 
and had neither taken any action on it nor discussed it as a business issue.  Providing 
managers with accurate, relevant information about the epidemic and practical prevention 
interventions might strengthen the business response to AIDS in countries like Nigeria. 
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Introduction 
 
Across sub-Saharan Africa, national governments, international agencies, and bilateral 
donors are looking to the private sector for leadership, resources, and action in the fight 
against HIV/AIDS.  A few companies have responded energetically, joining national and 
international AIDS business councils, implementing “best practice” prevention and 
treatment programs, and sponsoring local NGOs that educate communities and care for 
the sick and the orphans they leave behind.1  Many other companies have done little or 
nothing in response to the epidemic.  Understanding what motivates the first set of firms 
to take action while the second set does nothing would improve the ability of UNAIDS, 
the World Bank, governments, donors, and national business councils to adopt effective 
policies, target interventions, and plan for the future. 
 
Within the sub-Saharan region, Nigeria is of particular concern in the AIDS battle 
because of its large population, economic importance, newly democratic government, and 
fragile balance among ethnic and religious groups.  Using data from public antenatal 
clinics, Nigeria in 2001 estimated its mean adult HIV prevalence to be 5.8 percent.  This 
rate is modest in comparison to the double-digit rates of southern and eastern Africa, but 
given Nigeria’s large population it implies that the country has more than 3 million HIV-
positive adults.  Moreover, the national median rate masks tremendous geographic 
variation among the antenatal clinics surveyed, from a low of 1.0 percent to a high of 
15.0 percent.2‡  
 
In view of this geographic variation in HIV prevalence, one would expect that some 
Nigerian companies are losing employees to AIDS rather frequently, while others might 
have seen very little of the disease.  In March and April of 2001, we participated in a 
World Bank survey of some 230 formal-sector manufacturing firms in Nigeria, in an 
attempt to understand how AIDS is affecting Nigerian businesses, what they are doing 
about it, and why.§   
 
Methods 
 
Survey sample 
The survey was designed by the Regional Program for Enterprise Development of the 
World Bank’s Africa Region and implemented by World Bank staff and consultants and 
six teams of local interviewers recruited by the Nigerian offices of an international 
accounting firm.  It was administered to a representative, stratified sample of Nigerian 
manufacturing firms that were registered in the country in 1996.  Stratifiers included 
industrial sector, workforce size, and location.**  The 232 firms surveyed ranged in size 
from 5 employees to just under 5,000.  The human resources director or personnel 
                                                 
‡ The previous antenatal survey, carried out in 1999, revealed even greater variation, from 0.5 percent 
prevalence at the least affected sentinel site to 21 percent at the most.3 
§ The full results of the survey are described in the Regional Program for Enterprise Development, Africa 
Region, World Bank report, “The implications of HIV/AIDS for Nigerian manufacturing firms.  Results of 
the HIV/AIDS component of the RPED Nigeria survey, March-April 2001,” Center for International Health 
of the Boston University School of Public Health. 
** A detailed description of the sample frame and the final sample is contained in Marchat et al.4 
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manager in each firm was the principal respondent for the questions about HIV/AIDS.  If 
such a person did not exist within the firm or was unavailable, the owner or general 
manager was interviewed.     
 
Table 1 summarises the distribution of firms by industrial sector and size.  The firms 
represented 10 manufacturing sectors.  Of the 232 firms surveyed, 103 had fewer than 
100 employees, 95 had between 100 and 500 employees and 32 had more than 500 
employees.   
 
Statistical Analysis 
 
We used logistic regression models to analyse correlates of firm actions in response to 
HIV/AIDS. The dependent variables in the models referred to the following three 
possible actions: 
 
1. Firm provided information to employees:  handed out informational materials, put up 
posters, or arranged for speakers or performances about AIDS prevention. 
2. Firm undertook proactive prevention measures:  distributed condoms on company 
premises or trained employees to serve as peer educators or counsellors. 
3. Managers of the company have discussed HIV/AIDS as a potential business concern. 
 
We hypothesized that firms’ actions were influenced by the availability of information 
about HIV/AIDS, firm characteristics, and managers’ experience with the disease.  The 
independent variables we constructed to capture these effects can be categorized as 
follows: 
 
Variables related to information: 
 
• Firm received information about HIV/AIDS last year, from any source. 
• Firm received information from the government. 
• Firm received information from a health or medical organisation. 
 
Variables related to firm characteristics: 
 
• Ownership: private vs. government-owned, listed on the Nigerian stock market, 
ethnic origin of owners (if private). 
• Size: total number of employees, total annual sales. 
• Formal status and practices: legal rights to the business site, keeps accounts on an 
annual basis, has accounts audited by an outside agency. 
• Financial status: gross profits before taxes last accounting year. 
• International linkages: part of a family of firms or an industrial group, percent of 
production that is directly exported. 
• Medical: has on-site medical clinic. 
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Variables related to disease experience: 
 
• Someone currently working for the firm is known to be HIV-positive. 
• In the last two years, someone who worked for the firm died or left the company due 
to HIV/AIDS. 
• Median 2001 HIV prevalence rate at antenatal clinics in state where firm is located.  
We constructed this variable using the results of Nigeria’s 2001 antenatal clinic 
survey.2   Based on the antenatal HIV rates, we classified Nigerian states into three 
“prevalence regions,”  as shown in Table 2. 
 
We first estimated univariate models, in which we regressed each dependent variable on 
the independent variables one at a time. The final model was constructed using a 
backwards elimination selection process and confirmed with a forward selection process.  
Statistical analyses were carried out using the SAS System (SAS Institute Inc., Cary, NC) 
version 8.2.  Odds ratios and 95 percent confidence intervals were predicted from logistic 
regression parameter estimates and Wald confidence intervals using PROC LOGISTIC.  
 
Results 
 
Questions about firms’ awareness of HIV/AIDS, the actions they had taken, and the 
proportion of firms responding affirmatively to each question are shown in Table 3.  
More than 45 percent of the managers reported receiving information from outside the 
company about HIV/AIDS in the past year.  Of the firms that did receive information 
from external sources, the main sources of information were health or medical 
organisations (62.9 percent) or the government (48.5 percent).  Just 13.6 percent of the 
managers reported being aware of an AIDS-related death or retirement in the past two 
years, and even fewer—only 7.7 percent—knew of anyone in the company who was 
currently HIV positive.  
 
Almost a third (31.7 percent) of the managers reported company activities to prevent 
HIV/AIDS among employees.  Providing information, putting up posters, and arranging 
for speakers were far more frequent activities than those requiring a greater effort or 
investment, such as distributing condoms, training employees as peer educators and 
counsellors, treating STDs, or implementing HIV prevention projects in the community.  
Fewer than a quarter of the respondents (23.9 percent) reported that the managers of the 
company had discussed HIV/AIDS as a potential business concern.   
 
Table 4  shows the univariate odds ratios and 95 percent confidence intervals for 
correlates of actions that firms are taking against HIV/AIDS.  Correlates for providing 
information to employees included being listed on the Nigerian stock market, European 
ownership, large total number of employees, large gross profits, belonging to a family of 
firms or industrial group, having an on-site medical clinic, knowledge of someone 
currently in the workforce being HIV positive, and knowledge of someone who worked 
for the firm having died or left the company due to HIV/AIDS in the past two years.  
Correlates for taking more proactive prevention measures were the same as the correlates 
for providing information, with the exception of belonging to a family of firms or 
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industrial group.  Correlates for the managers of the firm discussing HIV/AIDS as a 
potential business concern were high percentage of government ownership, being listed 
on the Nigerian stock market, large number of employees, and knowledge of someone 
who worked for the firm having died or left the company due to HIV/AIDS in the past 
two years.   
 
Table 5 shows the multivariate regression odds ratios and 95 percent confidence intervals 
for correlates of actions that firms were taking against HIV/AIDS.  In these models, only 
those correlates that were statistically significant at the 0.05 level were included.  Having 
received information about HIV/AIDS last year from any source was a predictor common 
to all three actions.  Identifying someone with HIV/AIDS currently in the workforce or 
who left the firm due to HIV/AIDS in the past two years was a correlate of providing 
information to employees or taking proactive prevention measures.   
 
Discussion 
 
Involving the private sector in the social response to the HIV/AIDS epidemic is 
important.  The earlier the Nigerian business community engages with the issue, the 
greater chance it has to mitigate the types of economic impacts already seen in southern 
Africa.5  This study was the first in Nigeria to attempt to relate firm response to 
HIV/AIDS to firm characteristics, experience with HIV/AIDS, and the availability of 
information in order to understand which firms take action and why.   Identifying the 
determinants of business decisions, and thus the steps that international agencies, regional 
economic and political communities, national and local governments, and civil society 
can take to encourage a strong business response, will improve resource allocation, policy 
formulation, and program design. 
 
Our finding that managers’ first-hand knowledge of HIV-positive employees is strongly 
associated with decisions to take action is consistent with behavior-change experience in 
both developed and developing countries.6   The small number of managers who reported 
knowing of a current or former employee with HIV/AIDS might reflect the relatively low 
prevalence of HIV in some parts of Nigeria.  On the other hand, knowledge of an HIV-
positive employee or an AIDS death might also depend on how well-informed a manager 
is about AIDS and the health of the workforce.  In some parts of sub-Saharan Africa, the 
cause of death for those with AIDS is typically reported as an opportunistic infection or 
specific symptom.7  The stigma and potential sanctions associated with AIDS in Nigeria, 
moreover, mean that employees might go to great lengths to hide evidence of HIV 
infection from their employers.  For these reasons, we suspect that far more than 14 
percent of the companies in the survey had lost employees to AIDS and far more than 8 
percent had HIV-positive employees in their workforces at the time of the survey.   
 
The results of our survey can be considered both good news and bad.  To start with the 
bad news:  as of 2001, most of the Nigerian business managers sampled did not regard 
HIV/AIDS as a serious concern and had neither taken any action on it nor discussed it as 
a management issue.  While discouraging, this finding is not surprising when taken in the 
context of the climate for business in Nigeria overall.  Nigerian firms face extraordinarily 
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high costs for basic inputs, such as electricity and water, and for a range of transactions 
with government agencies (e.g. customs and tax collection services), labour unions, and 
private institutions like banks.4  We believe that these other problems are keeping HIV 
off the list of priority concerns of Nigerian managers—and may continue to do so for 
some time to come.  When combined with the fact that most Nigerian managers sampled 
in this survey believed they had never seen a case of AIDS, it is not difficult to 
understand their lack of concern.  Expectations that business will take a leading role in 
fighting the epidemic in Nigeria may thus be unrealistic, or at least premature.  At the 
same time, persuading managers to act now, before it is too late to stem the tide of the 
epidemic, is of critical importance. 
 
The good news is that it might be possible to influence firm behaviour through practical, 
low-cost interventions.  In this study of Nigerian firms, managers’ access to information 
and experience with AIDS in the workforce were significant predictors of action.  A 
program that provides high-quality, relevant information may thus be effective in 
improving the business response to AIDS.  Pressure from head offices of multinational 
corporations on their national subsidiaries also appeared to influence decisions.  
Voluntary, anonymous HIV seroprevalence surveys of workforces, a practice that has 
become common in South Africa,8 might prompt managers to take action if the surveys 
reveal that there are many more HIV-positive employees in the workforce than managers 
realize.  Promotion of voluntary counselling and testing (VCT) might achieve similar 
ends, if the aggregate results were available.  Ensuring that accurate, relevant information 
about HIV/AIDS prevalence, costs, risk factors, and prevention makes its way into 
boardrooms and executive offices—precisely the function of global and national business 
councils on AIDS—may not be sufficient to induce behaviour change, but it is almost 
certainly a necessary component of a broad and sustained business response.    
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Table 1:  Number of firms in the sample, classified by industrial sector and number 
of employees 
 
Number surveyed firms having: Industrial sector <100 employees 100-500 employees >500 employees Total 
Food or beverage processing 11 17 6 34 
Wood, furniture, or leather 14 4 1 19 
Textiles or garments 5 8 15 28 
Metal 10 20 1 31 
Machinery and tools 4 4 2 10 
Nonmetal 8 9 1 18 
Chemicals and paints 13 10 3 26 
Pharmaceuticals 11 8 2 21 
Plastics 14 8 1 23 
Paper/printing 13 7 0 20 
Total 103 95 32 230 
Note:  Of the 232 firms in the sample, 230 responded to the questions relevant to HIV/AIDS and were 
included in the analysis. 
 
Table 2:  Number of firms in the sample classified by 2001 HIV prevalence region 
 
Low prevalence region 
(<4% HIV prevalence) 
Medium prevalence region 
(4-8% HIV prevalence) 
High prevalence region 
(>8% HIV prevalence) 
Abia (15 firms, 3.3% 
prevalence) 
Anambra (14 firms, 6.5% 
prevalence) 
Benue (5 firms, 13.5% 
prevalence) 
Jigawa (3, 1.8%) Enugu (3, 5.2%) Plateau (4, 8.5%) 
Kano (32, 3.8%) Kaduna (17, 5.6%)  
Lagos (98, 3.5%) Kwara (4,  4.3%) (9 firms: 4% of total) 
Ogun (10, 3.5%) Oyo (17, 4.2%)  
 River (10,  7.7%)  
(158 firms: 68% of total)   
 (65 firms: 28% of total)  
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Table 3:  Proportion of managers responding affirmatively to questions about 
HIV/AIDS 
 
Question Number of firms 
whose managers 
responded to 
question (n)(a) 
Proportion 
responding 
“Yes” 
1. Did you receive any information from outside the company about 
HIV/AIDS last year?  
225 45.3% 
If “yes,” the source was: Proportion of those 
responding “Yes” 
  
Government 48.5%   
Religious organisation 11.0%   
Health or medical organisation 62.9%   
Other NGO 28.7%   
Other 7.4%   
2. To your knowledge, is anyone in your company currently HIV-
positive? 
196 7.7% 
3. To your knowledge, has anyone in your workforce died or left 
your company in the past two years due to HIV/AIDS? 
214 13.6% 
4. Did your firm undertake any activities in the last accounting year 
to prevent HIV/AIDS among employees? 
227 31.7% 
If yes, what did you do? Proportion of those 
responding “Yes” 
  
Handed out informational materials 61.6%   
Put up posters  64.4%   
Arranged for speakers or performances 
about AIDS prevention 70.3% 
  
Distributed condoms on company 
premises 34.7% 
  
Trained employees to serve as peer 
educators or counsellors 20.8% 
  
Provided additional resources for STD 
treatment 5.6% 
  
Implemented HIV prevention projects 
in the community 4.2% 
  
Other 10.3%   
5. Have the managers of your company discussed HIV/AIDS as a 
potential business concern? 
226 23.9% 
(a) Although a total of 232 firms participated in the survey, not all questions were answered by managers at 
all firms. 
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Table 4:  Univariate odds ratios and 95% confidence intervals for predictors of 
actions that firms are taking against HIV/AIDS 
 
Actions that firms are taking against HIV/AIDS Predictor 
Firm provided 
information to 
employees 
Firm undertook 
proactive prevention 
measures 
Managers of the firm 
have discussed 
HIV/AIDS as a potential 
business concern 
Government ownership (%) 1.00 (0.99 1.02) 1.00 (0.98 1.02) 1.02 (1.00 1.04)* 
Foreign ownership (%) 1.00 (0.99 1.01) 1.00 (0.99 1.01) 1.00 (0.99 1.01) 
Listed on Nigerian stock 
market  2.77 (1.34 5.72)* 5.952 (2.56 13.82)* 2.16 (1.00 4.66)* 
Indian ownership 0.99 (0.39 2.54) 1.03 (0.28 3.82) 1.17 (0.45 3.04) 
Lebanese ownership 0.85 (0.22 3.26) 0.00 (0.00 1000.00) 1.12 (0.29 4.39) 
European ownership 3.64 (1.26 10.5)* 4.92 (1.57 15.47)* 1.12 (0.34 3.72) 
Other ownership 1.89 (0.87 4.10) 1.37 (0.46 4.06) 1.03 (0.43 2.51) 
Total number of employees 1.00 (1.00 1.00)* 1.00 (1.00 1.00)* 1.00 (1.00 1.00)* 
Keeps accounts on an annual 
basis 0.93 (0.08 10.45) 0.31 (0.03 3.51) 0.16 (0.01 1.76) 
Accounts audited by an 
outside agency 3.18 (0.7 14.49) 2.320 (0.29 18.32) 2.01 (0.44 9.3) 
Gross profits before taxes last 
accounting year (millions of 
Naira) 
1.00 (1.00 1.01)* 1.00 (1.00 1.01)* 1.00 (1.00 1.01) 
Part of a family of firms or 
industrial group 2.66 (1.41 5.04)* 2.17 (0.89 5.30) 0.98 (0.52 1.85) 
Percent of production directly 
exported 1.02 (1.00 1.04) 0.99 (0.95 1.03) 1.02 (1.00 1.04) 
Has on-site medical clinic 4.18 (2.29 7.64)* 4.18 (1.87 9.35)* 1.86 (0.99 3.50) 
Someone in the firm is known 
to be HIV positive 4.16 (1.41 12.29)* 5.69 (1.82 17.73)* 2.33 (0.78 6.95) 
In the last two years someone 
who worked for the firm died 
or left the company due to 
HIV/AIDS 
6.91 (2.94 16.26)* 6.04 (2.45 14.87)* 2.348 (1.02 5.39)* 
Mean 2001 HIV antenatal 
prevalence rate in state where 
firm is located 
1.07 (0.93 1.23) 1.08 (0.90 1.29) 1.08 (0.93 1.26) 
* indicates significance at p < 0.05
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Table 5:  Multivariate odds ratios and 95% confidence intervals for predictors of 
actions that firms are taking against HIV/AIDS (only results that were statistically 
significant at the 5 percent level are shown) 
 
Actions that firms are taking against HIV/AIDS Predictor 
Firm provided 
information to 
employees 
Firm undertook 
proactive prevention 
measures 
Managers of the firm 
have discussed 
HIV/AIDS as a potential 
business concern 
Firm received information about 
HIV/AIDS last year, from any 
source 
7.83 (3.46 17.69) 9.64 (2.69 34.42) 2.77 (1.37, 5.59) 
Part of a family of firms or 
industrial group 2.86 (1.22 6.71)   
Has on-site medical clinic 2.22 (1.04 4.76)   
Someone in the firm is known to be 
HIV positive and/or In the last two 
years someone who worked for the 
firm died or left the company due 
to HIV/AIDS 
 
6.36 (2.30 17.57) 4.20 (1.57 11.25)  
Listed on Nigerian stock market   4.39 (1.60 12.05)  
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